Merck & Co., Inc. — Director's Dealing 2021

Nov 4, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2021-05-04

Reporting Person: Clyburn Frank (EVP & Pres ? Human Health)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-05-04	Restricted Stock Unit	$	A	39479	Acquired	2024-05-04	Common Stock (39479)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

F2: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in one installment on 5/4/2024.